logo
Select company
Select metric
$ 3.67MNet Cash Flow - Issuance (Purchase) of Equity Shares
VS
Market
29
Sector
52
Industry
64
History
85
$ 0.79Close
$ 0.57 - $ 6.41 52-Week Range
Ticker Information

Ticker

IBIO

Company Name

IBIO INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

IBIO INC - Net Cash Flow - Issuance (Purchase) of Equity Shares Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

IBIO - CF - Equity Historical data
DateNet Cash Flow - Issuance (Purchase) of Equity Shares
6/30/2025$ 3.67M
3/31/2025$ 15.49M
12/31/2024$ 18.53M
9/30/2024$ 22.62M
6/30/2024$ 25.72M
3/31/2024$ 15.12M
12/31/2023$ 14.68M
9/30/2023$ 13.4M
6/30/2023$ 11.45M
3/31/2023$ 7.81M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • IBIO INC's latest trailing twelve months (TTM) CF - Equity stands at $ 106.49M.
  • Over the past 5 years, IBIO INC's average CF - Equity has been $ 33.71M.
  • The median CF - Equity for IBIO INC during this period was $ 14.9M
  • IBIO INC reached its highest CF - Equity over the past 5 years at $ 139.56M.
  • The lowest CF - Equity recorded by IBIO INC in the same timeframe $ 77K

IBIO INC's CF - Equity vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CF - Equity Benchmarks
CompanyCF - Equity
PULM : PULMATRIX INC $ 0ERNA : ERNEXA THERAPEUTICS INC $ 5.93MLEXX : LEXARIA BIOSCIENCE CORP $ 6.05MVYNE : VYNE THERAPEUTICS INC $ 0BRTX : BIORESTORATIVE THERAPIES INC $ 2.05MABP : ABPRO HOLDINGS INC $ 10.36MMGRX : MANGOCEUTICALS INC $ 3.63MQCLS : Q/C TECHNOLOGIES INC $ 0HOTH : HOTH THERAPEUTICS INC $ 8.19MSYBX : SYNLOGIC INC $ 9K

Definition of Net Cash Flow - Issuance (Purchase) of Equity Shares

[Cash Flow Statement] A component of cash flow from financing [NCFF], representing the cash inflow (outflow) from stock issuance (purchase).

IBIO - Net Cash Flow - Issuance (Purchase) of Equity Shares, Last 5 years

$ 77K

Minimum

Jun 30, 2022

$ 139.56M

Maximum

Dec 31, 2020

$ 33.71M

Average

$ 14.9M

Median

CF - Equity Benchmark Analysis

The chart above depicts the distribution of CF - Equity for companies in the Total Stock Market. The average CF - Equity of the companies is $ 107.22K with a standard deviation of $ 17.65M.
The following table provides additional summary stats:
CF - Equity in the Market:
filtered constituents2.89K
min$ -60.59M
max$ 60.64M
average$ 107.22K
median$ 0
std$ 17.65M